CAR T Therapy Case Study Shows Early Success in Treatment of Acute Myeloid Leukemia – AJMC.com Managed Markets Network
Medical Xpress |
CAR T Therapy Case Study Shows Early Success in Treatment of Acute Myeloid Leukemia
AJMC.com Managed Markets Network In a new phase 1 trial called THINK (Therapeutic Immunotherapy with Natural Killer Group 2D [NKG2D]), published online in Haematologica, researchers are investigating Celyad's new CAR T therapy CYAD-01 in the treatment of acute myeloid leukemia (AML … New CAR T case study shows promise in acute myeloid leukemia |
